Kratom has a host of various alkaloids and chemical substances within it, as well as synthetic derivatives. These alkaloids and derivatives make it possible to have various medicinal applications for kratom. In lieu of this, H. Ridley conducted research in 1897 on Mitragyna speciosa, in order to discover its benefits and medical applications. Working within Indonesia, Ridley discovered the kratom was a cure for opium addiction, as well as those who suffered from severe itchiness, eczema, and dryness.
Crushing fresh kratom leaves and grinding them into paste would act as the perfect ointment for those seeking relief from their dryness. Moreover, kratom was gentle and sensitive enough to be used on the skins of little children and babies. Order Kratom online from this highly trusted vendor here.
The Ibogaine story about Kratom
Recently, reports have circulated that researchers in New Zealand have started researching upon kratom. They have discovered that those seeking detox and relief from methadone addiction can use the mitragynine found within kratom. The Ibogaine story was where this report was first published in New Zealand. Interestingly, drug cartels and pharmaceutical companies soon quashed any reports and news about this treatment.
This is why it was never published or heard of again, despite its effectiveness. According to The Ibogaine Story, users who experienced withdrawal symptoms from methadone addiction were told to smoke kratom leaves. This continued for a period of six weeks, after which they subject reported that their addiction had been completely cured. They no longer suffered from any debilitating side effects and withdrawal symptoms.
Moreover, subjects also reported hypnagogic dreams within the six periods, which points towards a visualization effect that took place during their treatment.
Diana Beal’s initiative research on Kratom
Diana Beal wished to conduct similar Ibogaine experiments within the United States of America. She was the leader of the group ‘Cure not Drugs’ and suggested the use of mitragynine as an active placebo. However, Diana’s initiative was rejected by the American Health Department and concerned authorities. This was because they claimed that very little was known about mitragynine, as opposed to Ibogaine. This uncertainty meant that it was not feasible to test patients with an unknown placebo. Many argued that Beal perhaps misinterpreted the results pertaining to Ibogaine.
Her initiative was helpful nonetheless because it spurred many more researchers, biologists, and botanists to carry their own research upon kratom.
Jansen and Prast’s Research Breakthrough
Furthermore, Jansen and Prast conducted extensive research on mitragynine in 1988, at the University of Auckland, New Zealand. They built their thesis upon H. Ridley’s work and discovered similar results. Their findings were published in the Journal of Ethnopharmacology, where they expounded upon the numerous medicinal benefits possessed by kratom.
They argued that not only did it aid methadone addiction, but helped with withdrawal symptoms associated with a range of other drugs as well. Moreover, kratom carried little to no side effects or negative and harmful consequences.
This made kratom a more viable, safer and feasible alternative than conventional medicines, which have a range of harmful side effects. Jansen and Prast’s research compelled the Australian National Drug Authority to reformulate its policy on kratom and its alkaloids.
Overall, what can be deduced is that kratom has a host of medical applications for a wide variety of users. These applications are not coupled with harmful or negative side effects, unlike other medication.
Rate This Article